Wound care continuity in home-based settings depends on a tightly controlled supply pathway that goes beyond simply having “some dressings in the home.” Healing trajectories, infection prevention, and skin integrity rely on the availability of the correct dressing type, appropriate compression systems, cleansing solutions, barrier products, and disposal materials at the right time and in the right combination. In HCBS and LTSS settings, disruption to any part of this pathway can rapidly lead to deterioration, infection, delayed healing, and avoidable escalation to urgent or acute care. Providers that treat wound supplies as routine ordering often fail to identify risk until a dressing change cannot be completed safely. High-performing organizations therefore govern wound care supply pathways within medication, equipment and supply chain continuity and align them directly with continuity of operations planning in HCBS and LTSS. They build inspection-grade systems that track exact reserve levels, define escalation thresholds, and ensure every sourcing and recovery action is auditable and time-bound.
System and oversight expectations
Funder expectation: Medicaid managed care organizations, waiver programs, and state oversight bodies expect providers supporting individuals with active wounds or high skin breakdown risk to demonstrate uninterrupted access to clinically appropriate dressing regimes, compression therapy, and hygiene supplies, particularly during foreseeable disruption events.
Regulatory expectation: CMS-aligned quality and infection prevention frameworks require providers to evidence continuity of wound care delivery, including documented supply availability, escalation pathways, and traceable responses when dressing or compression continuity is threatened.
Operational Example 1: Building a live wound care supply register for dressings, compression, and skin protection systems
What happens in day-to-day delivery
The Tissue Viability Lead requires all service users with active wounds, pressure injury risk, or compression therapy to be entered into a wound care supply register within the EHR. Step 1 is completed by the admitting RN or Wound Care Nurse during assessment and review: wound type classification, dressing regime specification including product name and frequency of change, and maximum safe delay before dressing change are recorded in the wound continuity profile along with prescribing clinician and next planned review date. Step 2 is completed by the Supplies Coordinator within two working days: current stock of primary dressings by type, secondary dressings or fixation products, and compression bandages or garments are entered into the wound supply tracker together with cleansing solution stock, barrier cream quantity, and next vendor delivery date.
Step 3 is completed during each visit by the Nurse or trained Support Worker: exact count of unused dressings by category, condition and packaging integrity of compression supplies, and availability of cleansing and disposal materials are documented in the mobile wound care review form before visit closure. Step 4 is completed weekly by the Team Leader: projected number of dressing changes remaining based on recorded frequency, households falling below a minimum of three full dressing cycles coverage, and any mismatch between prescribed regime and available stock are reviewed in the wound care dashboard and logged in the continuity action register. Step 5 is completed monthly by the Quality Lead: percentage of wound care cases with verified supply records, number of households with incomplete dressing regimes, and number of unresolved supply deficits are reviewed in the governance assurance report.
Why the practice exists (failure mode)
This practice exists because wound care failure often begins with incomplete regime continuity rather than total supply absence. A household may still have some dressings available, but not the correct type or sufficient quantity to complete the prescribed care plan. The failure mode is regime fragmentation, where incomplete supply data creates a false sense of readiness while the actual clinical pathway is already compromised. In system terms, this leads directly to delayed healing and increased infection risk.
What goes wrong if it is absent
Without a live wound care supply register, providers typically discover problems at the point of care, when the correct dressing is unavailable, compression cannot be applied, or cleansing supplies have run out. This results in improvised substitutions, missed or delayed dressing changes, and increased likelihood of wound deterioration or infection. It also weakens governance because the provider cannot evidence when the deficit became visible or whether preventative action was taken.
What observable outcome it produces
The observable outcome is improved continuity of prescribed wound care regimes and reduced risk of disruption-related deterioration. Providers can evidence this through reduced missed dressing changes, improved adherence to prescribed regimes, and fewer incidents involving supply-related delays. Evidence sources include EHR wound continuity profiles, wound supply trackers, mobile review forms, dashboards, and governance reports.
Operational Example 2: Activating threshold-based emergency sourcing for wound dressings and compression systems
What happens in day-to-day delivery
When dressing or compression supply reaches a predefined threshold, the On-Call Manager and Supplies Coordinator activate the emergency sourcing workflow within the same working hour. Step 1 is completed by the reporting staff member: dressing type at risk, exact quantity remaining, and number of dressing changes remaining at prescribed frequency are recorded in the continuity incident module together with timestamp and reporting source. Step 2 is completed by the RN or Wound Care Nurse: clinical urgency score, maximum safe delay before next dressing change, and interim care instruction are documented in the EHR clinical note along with escalation triggers such as increased exudate, odor, pain, or infection indicators.
Step 3 is completed by the Supplies Coordinator: vendor contacted, product availability confirmation including exact dressing type and quantity, and dispatch or collection time are recorded in the emergency sourcing log along with order reference number and authorization status. Step 4 is completed by the Logistics Lead: delivery route, named recipient, and estimated arrival time are documented in the transport tracker with contingency routing if delivery fails. Step 5 is completed by the receiving Nurse: delivered dressing quantities, confirmation of correct product type, and updated number of dressing cycles now available are recorded in the wound supply verification form within the mobile system and linked to the sourcing record before closure.
Why the practice exists (failure mode)
This workflow exists because wound care safety depends on timing as well as availability. The failure mode is delayed response, where staff recognize low supply but do not escalate quickly enough to prevent missed or unsafe dressing changes. Without structured escalation, the system fails to align clinical urgency with supply action.
What goes wrong if it is absent
If threshold-based sourcing is not implemented, providers may delay ordering, rely on partial stock, or attempt inappropriate substitutions. This leads to missed dressing changes, compromised wound environments, and increased infection risk. It also creates weak audit trails, as actions are reactive rather than threshold-driven and time-stamped.
What observable outcome it produces
The observable outcome is faster restoration of dressing and compression continuity, with fewer missed or delayed care interventions. Providers can evidence this through reduced threshold-to-delivery times, improved adherence to dressing schedules, and stronger completion of sourcing and verification records. Evidence sources include incident logs, sourcing logs, transport trackers, and verification forms.
Operational Example 3: Governing post-incident recovery and long-term wound supply stability
What happens in day-to-day delivery
The Quality Manager and Tissue Viability Lead oversee recovery following any wound care supply disruption. Step 1 is completed within one working day by the Care Coordinator: root cause classification such as vendor delay, incorrect forecasting, discharge failure, or authorization barrier, along with incident reference and current stock status, is recorded in the recovery register. Step 2 is completed by the RN: any impact on wound condition, missed or delayed dressing changes, and required follow-up review date are documented in the EHR. Step 3 is completed by the Supplies Coordinator: revised delivery schedule, confirmed reorder cycle, and updated minimum stock threshold are recorded in the supply stabilization tracker.
Step 4 is completed weekly by the Registered Manager: overdue corrective actions, repeat risk score, and completion of staff or caregiver education on stock monitoring are reviewed in the recovery dashboard. Step 5 is completed monthly by the Governance Committee: number of incidents by root cause, corrective action completion rates, and repeat incident patterns are reviewed in the board assurance report to inform system-level changes.
Why the practice exists (failure mode)
This recovery process exists because resolving a single supply issue does not eliminate underlying system weaknesses. The failure mode is repeat disruption, where the same forecasting or delivery issues recur due to lack of structured learning and corrective action.
What goes wrong if it is absent
Without recovery governance, providers repeatedly experience avoidable supply failures, increasing operational burden and risk to service users. It also prevents identification of systemic issues, weakening both care quality and audit defensibility.
What observable outcome it produces
The observable outcome is improved long-term stability of wound care supply pathways, with reduced recurrence of incidents and stronger governance oversight. Evidence includes recovery registers, dashboards, and board-level reports demonstrating improved performance trends.
Conclusion
Wound care continuity requires more than availability of individual products; it requires a fully governed supply pathway aligned to clinical regimes, timing, and risk thresholds. Providers that implement inspection-grade reserve tracking, escalation workflows, and recovery governance are better positioned to protect healing outcomes, prevent infection, and demonstrate defensible practice. In HCBS and LTSS settings, wound care continuity is only credible when every step from stock verification to recovery learning is visible, auditable, and consistently applied.